EP2675469A4
(en )
2015-04-08
Compositions, devices and methods of use thereof for the treatment of cancers
TR201813877T4
(en )
2018-11-21
COMPOUNDS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY.
EA201171367A1
(en )
2012-04-30
VINYLINDASOLYL COMPOUNDS
CL2012003385A1
(en )
2013-04-05
Incontinence treatment.
EP4324527A3
(en )
2024-04-24
Formulations of enzalutamide
MX2013008390A
(en )
2013-08-12
Preparation of metal-triazolate frameworks.
NZ628294A
(en )
2017-11-24
Compositions and methods of use of phorbol esters for the treatment of stroke
EA201490559A1
(en )
2014-09-30
COMPOSITION FOR THE TREATMENT OF Fistula
MX2014012477A
(en )
2014-12-10
Pyrrolopyrazone inhibitors of tankyrase.
JO3755B1
(en )
2021-01-31
Testosterone formulations
IL235429A0
(en )
2014-12-31
(r)-nifuratel, its use for the treatment of infections and synthesis of (r) and (s)-nifuratel
IN2014DN11078A
(en )
2015-09-25
GEP201706636B
(en )
2017-03-10
Galactagogue compositions based on phosphatidylserine
IN2014KN01772A
(en )
2015-10-23
UA57317U
(en )
2011-02-25
use of Corvitine as agent for treatment of acute craniocerebral injury
PT2456445E
(en )
2014-07-17
Agent for the treatment of skin conditions
MX2012012509A
(en )
2012-12-05
Tapentadol for use in the treatment of irritable bowel syndrome.
UA52379U
(en )
2010-08-25
use of lipine as agent with frigoprotective action
UA52378U
(en )
2010-08-25
use of lipoflavon as agent with frigoprotective action
UA52376U
(en )
2010-08-25
use of corvitine as agent with frigoprotective action
UA62955U
(en )
2011-09-26
use of aspenbark extract as an agent of adaptogenic action
UA96059C2
(en )
2011-09-26
Use of lipin as agent with frigoprotective action
UA52370U
(en )
2010-08-25
use of glucosamine hydrochloride as agent with frigoprotective action
UA58160U
(en )
2011-04-11
use of Lipoflavon for treatment of cerebrovascular trauma
UA96060C2
(en )
2011-09-26
Use of lipoflavone as agent with frigoprotective action